Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERDAL CONSTA vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERDAL CONSTA vs RITUXIMAB: Safety Overview

Metric RISPERDAL CONSTA RITUXIMAB
Total FAERS Reports 140 178,614
Deaths Reported 29 28,910
Death Rate 20.7% 16.2%
Hospitalizations 56 54,631
Average Patient Age 45.0 yrs 54.6 yrs
% Female Patients N/A 64.3%
Manufacturer N/A Genentech, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription